Edmp, Inc. Amgen Inc Transaction History

Edmp, Inc.

$120 Million
Q3 2024

A detailed history of Edmp, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Edmp, Inc. holds 16,769 shares of AMGN stock, worth $4.74 Million. This represents 4.49% of its overall portfolio holdings.

Number of Shares

16,769

Previous 17,172 2.35%

Holding current value

$4.74 Million

Previous $5.37 Million 0.71%

% of portfolio

4.49%

Previous 4.92%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$309.38 - $337.38 $124,680 - $135,964	-403 Reduced 2.35%	16,769 $5.4 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $53,338 - $64,819	-203 Reduced 1.17%	17,172 $5.37 Million
Q1 2024 Apr 24, 2024	BUY	$268.87 - $324.56 $14,250 - $17,201	53 Added 0.31%	17,375 $4.94 Million
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $47,560 - $53,653	-186 Reduced 1.06%	17,322 $4.99 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $106,919 - $132,743	489 Added 2.87%	17,508 $4.71 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $9,642 - $11,401	45 Added 0.27%	17,019 $3.78 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $70,898 - $86,412	-314 Reduced 1.82%	16,974 $4.1 Million
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $1.04 Billion - $1.32 Billion	-4,523,158 Reduced 99.62%	17,288 $4.54 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $1.04 Billion - $1.32 Billion	4,522,722 Added 25517.5%	4,540,446 $1.19 Billion
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $28,281 - $31,896	-126 Reduced 0.71%	17,724 $4 Million
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $43,142 - $48,010	187 Added 1.06%	17,850 $4.34 Million
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $174,977 - $193,570	-798 Reduced 4.32%	17,663 $4.27 Million
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $39,776 - $45,520	-200 Reduced 1.07%	18,461 $4.15 Million
Q3 2021 Oct 20, 2021	BUY	$212.27 - $248.7 $110,592 - $129,572	521 Added 2.87%	18,661 $3.97 Million
Q2 2021 Jul 19, 2021	SELL	$233.58 - $259.14 $53,723 - $59,602	-230 Reduced 1.25%	18,140 $4.42 Million
Q1 2021 Apr 20, 2021	SELL	$221.91 - $258.6 $161,328 - $188,002	-727 Reduced 3.81%	18,370 $4.57 Million
Q4 2020 Jan 12, 2021	SELL	$216.38 - $257.67 $83,955 - $99,975	-388 Reduced 1.99%	19,097 $4.39 Million
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $129,057 - $143,522	-550 Reduced 2.75%	19,485 $4.95 Million
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $151,720 - $186,181	-767 Reduced 3.69%	20,035 $4.73 Million
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $149,619 - $198,435	-821 Reduced 3.8%	20,802 $4.22 Million
Q4 2019 Jan 21, 2020	SELL	$189.21 - $243.2 $78,143 - $100,441	-413 Reduced 1.87%	21,623 $5.21 Million
Q3 2019 Oct 16, 2019	SELL	$174.11 - $208.62 $117,001 - $140,192	-672 Reduced 2.96%	22,036 $4.51 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $204,374 - $239,572	-1,226 Reduced 5.12%	22,708 $4.19 Million
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $33,460 - $37,717	-185 Reduced 0.77%	23,934 $4.55 Million
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $79,388 - $92,671	-445 Reduced 1.81%	24,119 $4.7 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $2,779 - $3,133	-15 Reduced 0.06%	24,564 $5.09 Million
Q2 2018 Jul 25, 2018	SELL	$166.05 - $186.51 $114,740 - $128,878	-691 Reduced 2.73%	24,579 $4.54 Million
Q1 2018 Apr 11, 2018	SELL	$169.43 - $198.0 $18,976 - $22,176	-112 Reduced 0.44%	25,270 $4.31 Million
Q4 2017 Jan 16, 2018	SELL	$168.79 - $188.59 $172,165 - $192,361	-1,020 Reduced 3.86%	25,382 $4.7 Million
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $4.42 Million - $5.04 Million	26,402	26,402 $4.92 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Edmp, Inc. with notifications on news.

Account